Dickerson F, Jones-Brando L, Ford G, et al. Schizophrenia is Associated With an Aberrant Immune Response to Epstein-Barr Virus. Schizophr Bull. 2019;45(5):1112-1119. doi:10.1093/schbul/sby164.

Frost TC, Gewurz BE. Epigenetic crossroads of the Epstein-Barr virus B-cell relationship. Curr Opin Virol. 2018;32:15-23. doi:10.1016/j.coviro.2018.08.012.

Ma Y, Walsh MJ, Bernhardt K, et al. CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors. Cell Host Microbe. 2017;21(5):580-591.e7. doi:10.1016/j.chom.2017.04.005.

Weiss ER, Lamers SL, Henderson JL, et al. Early Epstein-Barr Virus Genomic Diversity and Convergence toward the B95.8 Genome in Primary Infection. J Virol. 2018;92(2). doi:10.1128/JVI.01466-17.

Gebre M, Nomburg JL, Gewurz BE. CRISPR-Cas9 Genetic Analysis of Virus-Host Interactions. Viruses. 2018;10(2). doi:10.3390/v10020055.

Choy E, Yelensky R, Bonakdar S, et al. Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines. PLoS Genet. 2008;4(11):e1000287. doi:10.1371/journal.pgen.1000287.

Pegtel M, Subramanian A, Meritt D, et al. IFN-alpha-stimulated genes and Epstein-Barr virus gene expression distinguish WHO type II and III nasopharyngeal carcinomas. Cancer Res. 2007;67(2):474-81. doi:10.1158/0008-5472.CAN-06-1882.

Pegtel DM, Subramanian A, Sheen T-S, Tsai C-H, Golub TR, Thorley-Lawson DA. Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J Virol. 2005;79(24):15430-42. doi:10.1128/JVI.79.24.15430-15442.2005.

Kang M-S, Lee EK, Soni V, et al. Roscovitine inhibits EBNA1 serine 393 phosphorylation, nuclear localization, transcription, and episome maintenance. J Virol. 2011;85(6):2859-68. doi:10.1128/JVI.01628-10.

Arvey A, Ojesina AI, Pedamallu CS, et al. The tumor virus landscape of AIDS-related lymphomas. Blood. 2015;125(20):e14-22. doi:10.1182/blood-2014-11-599951.